142733-19-5
Chemical Structure
HA-29
- CAS No.: 142733-19-5
- Formula:C16H16N2O3
- Molecular Weight:284.32
IUPAC Name: 2-(3-methoxybenzyl)-3,4-dimethylpyrano[2,3-c]pyrazol-6(2H)-one
InChIKey: BGQCLOJXGUOCGK-UHFFFAOYSA-N
SMILES: O=C1OC2=NN(C(=C2C(=C1)C)C)CC=3C=CC=C(OC)C3
Biological Activity: HA-29 is an antiplatelet aggregation agent. HA-29 acts as a cyclooxygenase inhibitor and a thromboxane A2/prostaglandin endoperoxide receptor antagonist. HA-29 exerts its effects by inhibiting cyclooxygenase to block the formation of thromboxane A2 (TXA2), while simultaneously blocking the TXA2/prostaglandin endoperoxide receptor on platelets as a non-competitive antagonist. HA-29 can be used in antithrombotic research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
HA-29 | HA-29 is an antiplatelet aggregation agent. HA-29 acts as a cyclooxygenase inhibitor and a thromboxane A2/prostaglandin endoperoxide receptor antagonist. HA-29 exerts its effects by inhibiting cyclooxygenase to block the formation of thromboxane A2 (TXA2), while simultaneously blocking the TXA2/prostaglandin endoperoxide receptor on platelets as a non-competitive antagonist. HA-29 can be used in antithrombotic research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
